Emergent BioSolutions (EBS) Other Accumulated Expenses (2018 - 2026)
Emergent BioSolutions (EBS) posted Other Accumulated Expenses of $9.9 million for Q2 2026, up 23.75% on a QoQ basis from $8.0 million in Q1 2026, and down 27.21% year-over-year from $13.6 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Emergent BioSolutions has reported Other Accumulated Expenses for 9 years, with the latest figure at $9.9 million in Q2 2026.
- On a quarterly basis, Other Accumulated Expenses fell 27.21% year-over-year to $9.9 million in Q2 2026; TTM through Jun 2026 was $9.9 million, a 27.21% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 50.68% from the prior year.
- Other Accumulated Expenses was $9.9 million for Q2 2026 at Emergent BioSolutions, up from $8.0 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $67.6 million in Q3 2024, with the low at $8.0 million in Q1 2026.
- Average Other Accumulated Expenses over 5 years is $24.4 million, with a median of $24.0 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses slumped 79.84% in 2022, then surged 76.96% in 2024.
- Over 5 years, Other Accumulated Expenses stood at $45.9 million in 2022, then retreated by 28.76% to $32.7 million in 2023, then slumped by 33.03% to $21.9 million in 2024, then plunged by 50.68% to $10.8 million in 2025, then decreased by 8.33% to $9.9 million in 2026.
- The last three Other Accumulated Expenses figures came in at $9.9 million (Q2 2026), $8.0 million (Q1 2026), and $10.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Sep 30, 2025 | 24.10 Mn |
| Jun 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 21.90 Mn |
| Sep 30, 2024 | 67.60 Mn |
| Jun 30, 2024 | 14.60 Mn |
| Mar 31, 2024 | 14.50 Mn |
| Dec 31, 2023 | 32.70 Mn |
| Sep 30, 2023 | 38.20 Mn |
| Jun 30, 2023 | 28.90 Mn |
| Mar 31, 2023 | 25.20 Mn |
| Dec 31, 2022 | 45.90 Mn |
| Sep 30, 2022 | 24.00 Mn |
| Jun 30, 2022 | 24.20 Mn |
| Mar 31, 2022 | 24.60 Mn |
| Dec 31, 2021 | 73.10 Mn |
| Sep 30, 2021 | 82.30 Mn |
API Access
Emergent BioSolutions Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();